HIGHLIGHTS
- who: Han Cao from the Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China have published the article: Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients, in the Journal: (JOURNAL)
- what: Total of 43 differential metabolites including free fatty acids acylcarnitines and dicarboxylic acids were accurately identified in study cohort 1 and the analysis showed that lipid metabolism was impaired in psoriasis patients. In this study, metabolomic analysis was conducted on two study cohorts . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.